MANGIACAPRA, FABIO
 Distribuzione geografica
Continente #
AS - Asia 4.485
NA - Nord America 856
EU - Europa 408
SA - Sud America 81
OC - Oceania 35
AF - Africa 14
Totale 5.879
Nazione #
SG - Singapore 3.909
US - Stati Uniti d'America 831
CN - Cina 322
IT - Italia 133
HK - Hong Kong 111
VN - Vietnam 66
GB - Regno Unito 59
DE - Germania 57
BR - Brasile 56
NL - Olanda 41
CZ - Repubblica Ceca 39
AU - Australia 35
IN - India 27
AR - Argentina 13
CA - Canada 13
FI - Finlandia 12
ID - Indonesia 10
IR - Iran 9
MX - Messico 9
FR - Francia 8
PL - Polonia 8
BE - Belgio 7
ZA - Sudafrica 7
PK - Pakistan 6
EC - Ecuador 5
JP - Giappone 5
LT - Lituania 5
RO - Romania 4
RU - Federazione Russa 4
UA - Ucraina 4
AT - Austria 3
DO - Repubblica Dominicana 3
PH - Filippine 3
RS - Serbia 3
SE - Svezia 3
TR - Turchia 3
TW - Taiwan 3
CL - Cile 2
CO - Colombia 2
LU - Lussemburgo 2
NO - Norvegia 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.879
Città #
Ashburn 381
Singapore 157
Dallas 123
Hong Kong 109
Hefei 100
Beijing 69
Boardman 64
Rome 58
London 46
Munich 31
Amsterdam 29
Brno 27
Shanghai 25
Ho Chi Minh City 22
Perth 22
Council Bluffs 21
Los Angeles 19
San Francisco 16
West Jordan 16
Hanoi 13
Seattle 11
Olomouc 10
Santa Clara 9
Bengaluru 8
Washington 8
Milan 7
New York 7
Bocholt 6
Brooklyn 6
Helsinki 6
Mexico City 6
Montreal 6
Chennai 5
Johannesburg 5
Surat 5
São Paulo 5
Turku 5
Warsaw 5
Bologna 4
Hanover 4
Melbourne 4
Nuremberg 4
Pune 4
Quận Ninh Kiều 4
Shijiazhuang 4
Tokyo 4
Târgu Mureş 4
Xi'an 4
Zhengzhou 4
Zhoukou 4
Atlanta 3
Aubin Grove 3
Boston 3
Conroe 3
Da Nang 3
Guangzhou 3
Haiphong 3
Karachi 3
Manchester 3
Stuttgart 3
Taipei 3
Aberdeen 2
Ankara 2
Aversa 2
Belgrade 2
Borås 2
Buffalo 2
Bắc Ninh 2
Campinas 2
Castagnole 2
Catania 2
Chicago 2
Ciampino 2
Diadema 2
Durham 2
Florence 2
Gold Coast 2
Greenville 2
Hamar 2
Jequié 2
Jinan 2
Krakow 2
Liaocheng 2
Louisville 2
Luxembourg 2
Lấp Vò 2
Maceió 2
Mainz 2
Miami 2
Ningbo 2
North Bergen 2
Palermo 2
Philadelphia 2
Porto Alegre 2
Qingdao 2
Queens 2
Quilmes 2
Ravenna 2
San Jose 2
Santo Domingo 2
Totale 1.627
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 414
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 234
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 216
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 212
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 205
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 204
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 201
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 200
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 199
Current management and prognosis of patients with recurrent myocardial infarction 198
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients) 190
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 188
Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure 181
Gender-Based Specificities of Fractional Flow Reserve Measurement 178
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 176
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. 172
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 163
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 146
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 143
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 111
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 109
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 105
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 104
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 101
High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality 97
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention 97
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 97
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 97
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 94
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 89
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 85
Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention 83
Invasive Assessment of Coronary Microvascular Function 81
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 79
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 73
CARDIAC ANTHRACYCLINE ACCUMULATION AND B-TYPE NATRIURETIC PEPTIDE TO DEFINE RISK AND PREDICTORS OF CANCER TREATMENT RELATED EARLY DIASTOLIC DYSFUNCTION 71
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 62
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 53
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis 52
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 42
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 41
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients 39
Impact of Tourniquet Use on Systemic Inflammatory Parameters, Functional Physical Recovery, and Cardiovascular Outcomes of Patients Undergoing Knee Arthroplasty: A Case-Control Study 35
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 34
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 34
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 30
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio 29
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 26
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 24
Idiopathic sensorineural hearing loss is associated with endothelial dysfunction 21
Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention 18
Totale 5.933
Categoria #
all - tutte 21.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 2 3 0 0 0 0 0 0 7 43
2022/202369 2 2 5 9 12 0 0 3 2 0 34 0
2023/2024555 3 18 17 26 14 71 33 265 31 28 10 39
2024/20254.343 54 17 72 30 25 67 58 35 113 259 1.695 1.918
2025/2026911 185 170 160 209 114 73 0 0 0 0 0 0
Totale 5.933